August 7, 2025
Jeff Aronin, Aspen Institute Trustee and founder, chairman, and CEO of Paragon Biosciences, leads a conversation with neuroscientist and best-selling author Lisa Feldman Barrett about her book…
September 28, 2023
MATTER Chairman and Founder, Jeff Aronin was honored by Illinois Gov., JB Pritzker, former Chicago Mayor Rahm Emanuel and other dignitaries for his service to the life sciences community.
Summer 2023
Watch Jeff Aronin lead this Aspen Ideas: Health conversation about unmet medical needs for people with sleep disorders and the overlooked impact of sleep on overall health.
January 11, 2023
In this interview with Insights Success, Jeff Aronin discusses Paragon Biosciences’ portfolio company Evozyne’s role in technical advancements in genetics and supercomputing…
Chad Mirkin, the most cited chemist in the world in 2010 and a world-renowned scientific innovator, discusses his entrepreneurial approach with Paragon Biosciences…
MATTER Chairman and Founder, Jeff Aronin was honored by Illinois Gov., JB Pritzker, former Chicago Mayor Rahm Emanuel and other dignitaries for his service to the life sciences community.
Jeff Aronin, Aspen Institute Trustee and founder, chairman, and CEO of Paragon Biosciences, leads a conversation with neuroscientist and best-selling author Lisa Feldman Barrett about her book…
Watch Jeff Aronin lead this Aspen Ideas: Health conversation about unmet medical needs for people with sleep disorders and the overlooked impact of sleep on overall health.
In this interview with Insights Success, Jeff Aronin discusses Paragon Biosciences’ portfolio company Evozyne’s role in technical advancements in genetics and supercomputing…
Chad Mirkin, the most cited chemist in the world in 2010 and a world-renowned scientific innovator, discusses his entrepreneurial approach with Paragon Biosciences…
Jeff recently spoke with Pulitzer-prize winning journalist Kathleen Gallagher on her podcast “How Did You Do That?”, discussing his expansive career in life sciences…
Jeff Aronin discusses why Paragon Biosciences’ unique company incubator approach results in an 80%–90% approval rate on new drug applications, far exceeding that of the traditional pharma industry. Read more about Jeff Aronin’s take on…
